Content by Drug Discovery News
Researchers are uncovering new ways to attack some of cancer’s most elusive drivers.
| 1 min read
The toughest problem to solve in drug development may not be finding new medicines, but building the infrastructure to make them reliably.
Available on Demand
Gain insight into how microbiome research is advancing the understanding of cancer biology and therapeutic outcomes.
Explore how AI-assisted analysis reveals coordinated neuronal activity and network development in brain organoid models.
Learn how mass spectrometry-based proteomics is helping researchers identify biomarker signatures that stratify patients and predict disease outcomes.
Learn how researchers isolated transient B cell populations to uncover a previously unrecognized mechanism of antibody maturation.
Explore key challenges and practical considerations that shape reliable and reproducible mass spectrometry workflows.
Advances in high-dimensional flow cytometry and integrated imaging are enabling deeper, more reproducible insights into cellular behavior.
Explore how combining 3D liver microtissue models with AI-driven image analysis enhances the accuracy and depth of hepatotoxicity assessment.
Available on Demand
Learn how advances in multiplex immunofluorescence are enabling scalable, high-dimensional spatial biomarker analysis for clinical trials.
Discover strategies to minimize metal-analyte interactions to improve chromatographic performance and small molecule analysis.
Innovations in chromatographic system design are helping scientists improve analytical reliability and generate higher-quality data for challenging compounds.
